FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092168085> ?p ?o ?g. }

• W2092168085 endingPage "144" @default.
• W2092168085 startingPage "131" @default.
• W2092168085 abstract "The Epstein-Barr virus-encoded protein BCRF1 (viral interleukin [vIL]-10) is a biologically active homologue of cellular interleukin (IL)-10. In this study, a novel gene therapy approach to prolong allograft survival was designed. Autologous (syngeneic) hematopoietic progenitor/stem cell-enriched (HSC; lineage(-ve)) population derived from CBA/J mouse bone marrow were transduced with retrovirus encoding vIL-10 gene (vIL-10-HSC), ex vivo; vIL-10-HSC were injected (4-6 x 10(6) cells intravenously) into lethally (9.5 Gy) or sublethally (4 Gy) irradiated CBA/J mice. Six weeks after vIL-10-HSC administration, vascular heterotopic heart (C57BL/6) transplantation was performed. Ex vivo, the vIL-10-HSC produced 5.4 +/- 0.5 ng of vIL-10 protein/2 x 10(5) cells per 24 hr. In vivo, serum vIL-10 production was 187 +/- 205 pg/ml during 3-10 weeks after vIL-10-HSC administration. Cardiac allograft survival was prolonged (p < 0.004) in lethally (71 +/- 40 days) and sublethally (114 +/- 15 days) irradiated mice that received vIL-10-HSC compared to controls that received unengineered (UE) HSC or vector DNA-engineered HSC (12-16 days). However, secondary skin graft (C57BL/6) survival was not prolonged in cardiac allograft-tolerant animals. In the vIL-10-HSC-administered group, graft histopathology demonstrated mild arteritis/venulitis (grade 0.7) and rejection (grade 1.0). Intragraft expression of costimulatory molecules (B7.1, B7.2), cytokines (IL-2, IL-4, mIL-10, interferon [IFN]-gamma), and inducible nitric oxide synthase (iNOS) molecules was markedly lower in vIL-10-HSC-treated tolerant grafts that survived more than 100 days compared to vector DNA-HSC- or UE-HSC-treated controls. Furthermore, T lymphocytes derived from vIL-10-HSC-treated tolerant recipients demonstrated hyporeactivity to donor antigens in mixed lymphocyte cultures. Administration of autologous vIL-10-engineered HSC prior to organ transplantation prolonged cardiac allograft survival significantly." @default.
• W2092168085 created "2016-06-24" @default.
• W2092168085 creator A5011324763 @default.
• W2092168085 creator A5016888338 @default.
• W2092168085 creator A5042901739 @default.
• W2092168085 creator A5056568620 @default.
• W2092168085 creator A5069779721 @default.
• W2092168085 date "2004-02-01" @default.
• W2092168085 modified "2023-09-23" @default.
• W2092168085 title "Viral Interleukin-10–Engineered Autologous Hematopoietic Stem Cell Therapy: A Novel Gene Therapy Approach to Prevent Graft Rejection" @default.
• W2092168085 cites W1515615230 @default.
• W2092168085 cites W1517658874 @default.
• W2092168085 cites W1549990240 @default.
• W2092168085 cites W1553215445 @default.
• W2092168085 cites W1639400191 @default.
• W2092168085 cites W1657750667 @default.
• W2092168085 cites W1863689575 @default.
• W2092168085 cites W1943760307 @default.
• W2092168085 cites W1962142522 @default.
• W2092168085 cites W1967942756 @default.
• W2092168085 cites W1968492586 @default.
• W2092168085 cites W1983821366 @default.
• W2092168085 cites W1983995896 @default.
• W2092168085 cites W1985556669 @default.
• W2092168085 cites W1989375384 @default.
• W2092168085 cites W1990458269 @default.
• W2092168085 cites W1994527381 @default.
• W2092168085 cites W2006334286 @default.
• W2092168085 cites W2011502022 @default.
• W2092168085 cites W2012241435 @default.
• W2092168085 cites W2027217273 @default.
• W2092168085 cites W2028489212 @default.
• W2092168085 cites W2031276819 @default.
• W2092168085 cites W2036821888 @default.
• W2092168085 cites W2040456037 @default.
• W2092168085 cites W2041469322 @default.
• W2092168085 cites W2047999732 @default.
• W2092168085 cites W2052906017 @default.
• W2092168085 cites W2055336483 @default.
• W2092168085 cites W2060546545 @default.
• W2092168085 cites W2065414629 @default.
• W2092168085 cites W2069335522 @default.
• W2092168085 cites W2072391555 @default.
• W2092168085 cites W2079701626 @default.
• W2092168085 cites W2083132915 @default.
• W2092168085 cites W2083466222 @default.
• W2092168085 cites W2083543917 @default.
• W2092168085 cites W2086449142 @default.
• W2092168085 cites W2088031551 @default.
• W2092168085 cites W2102121190 @default.
• W2092168085 cites W2102942510 @default.
• W2092168085 cites W2104806444 @default.
• W2092168085 cites W2107361191 @default.
• W2092168085 cites W2110190262 @default.
• W2092168085 cites W2115912600 @default.
• W2092168085 cites W2116878408 @default.
• W2092168085 cites W2132415356 @default.
• W2092168085 cites W2133556861 @default.
• W2092168085 cites W2134677648 @default.
• W2092168085 cites W2144868114 @default.
• W2092168085 cites W2149301933 @default.
• W2092168085 cites W2150195134 @default.
• W2092168085 cites W2151092270 @default.
• W2092168085 cites W2155742277 @default.
• W2092168085 cites W2161074777 @default.
• W2092168085 cites W2169056709 @default.
• W2092168085 cites W2171757778 @default.
• W2092168085 cites W2191654227 @default.
• W2092168085 cites W2330760708 @default.
• W2092168085 cites W2333378480 @default.
• W2092168085 cites W4234064784 @default.
• W2092168085 cites W4243998405 @default.
• W2092168085 doi "https://doi.org/10.1089/104303404772679940" @default.
• W2092168085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14975186" @default.
• W2092168085 hasPublicationYear "2004" @default.
• W2092168085 type Work @default.
• W2092168085 sameAs 2092168085 @default.
• W2092168085 citedByCount "23" @default.
• W2092168085 countsByYear W20921680852012 @default.
• W2092168085 countsByYear W20921680852014 @default.
• W2092168085 countsByYear W20921680852016 @default.
• W2092168085 countsByYear W20921680852020 @default.
• W2092168085 countsByYear W20921680852022 @default.
• W2092168085 crossrefType "journal-article" @default.
• W2092168085 hasAuthorship W2092168085A5011324763 @default.
• W2092168085 hasAuthorship W2092168085A5016888338 @default.
• W2092168085 hasAuthorship W2092168085A5042901739 @default.
• W2092168085 hasAuthorship W2092168085A5056568620 @default.
• W2092168085 hasAuthorship W2092168085A5069779721 @default.
• W2092168085 hasConcept C104317684 @default.
• W2092168085 hasConcept C109159458 @default.
• W2092168085 hasConcept C111599444 @default.
• W2092168085 hasConcept C126322002 @default.
• W2092168085 hasConcept C150903083 @default.
• W2092168085 hasConcept C201750760 @default.
• W2092168085 hasConcept C203014093 @default.
• W2092168085 hasConcept C207001950 @default.
• W2092168085 hasConcept C26291073 @default.

• next